Drug Profile
Heparin binding neurotrophic factor
Latest Information Update: 09 Jul 2002
Price :
$50
*
At a glance
- Originator Regeneron Pharmaceuticals; Wyeth
- Class Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 09 Jul 2002 Discontinued - Preclinical for Neurological disorders in USA (unspecified route)
- 13 Oct 2000 Profile reviewed but no significant changes made
- 05 Oct 1998 No-Development-Reported for Neurological disorders in USA (Unknown route)